These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7962779)

  • 1. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
    Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring patients taking methotrexate.
    Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1995 Apr; 32(4):680. PubMed ID: 7896967
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis.
    Arias JM; Morton KA; Albro JE; Patch GG; Valdivia S; Greenberg HE; Christian PE; Datz FL
    J Nucl Med; 1993 Nov; 34(11):1905-9. PubMed ID: 8229232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
    Erickson AR; Reddy V; Vogelgesang SA; West SG
    Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well.
    Kremer JM
    J Rheumatol; 2002 Aug; 29(8):1590-2. PubMed ID: 12180714
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity of methotrexate in rheumatic diseases.
    Kevat S; Ahern M; Hall P
    Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
    Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S
    Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood?
    Tang H; Neuberger J
    Aliment Pharmacol Ther; 1996 Dec; 10(6):851-8. PubMed ID: 8971280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate hepatotoxicity.
    West SG
    Rheum Dis Clin North Am; 1997 Nov; 23(4):883-915. PubMed ID: 9361160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver biopsy in methotrexate treatment.
    Zachariae H; Schiodt T
    Acta Derm Venereol; 1971; 51(3):215-20. PubMed ID: 4103033
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
    Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transaminitis and neutropenia are rare in patients on methotrexate: evidence from a large cohort of inflammatory arthritis patients.
    Malley T; Corfield G; Fung P; Heneghan D; Kitchen J
    Rheumatology (Oxford); 2019 Nov; 58(11):2061-2062. PubMed ID: 31081042
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate and the liver.
    Dahl MG
    Br J Dermatol; 1969 Jun; 81(6):465-7. PubMed ID: 4891127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.